These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11081758)

  • 1. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice.
    Gock H; Salvaris E; Murray-Segal L; Mottram P; Han W; Pearse MJ; Goodman DJ; Cowan PJ; d'Apice AJ
    Xenotransplantation; 2000 Nov; 7(4):237-46. PubMed ID: 11081758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection.
    Pearse MJ; Witort E; Mottram P; Han W; Murray-Segal L; Romanella M; Salvaris E; Shinkel TA; Goodman DJ; d'Apice AJ
    Transplantation; 1998 Sep; 66(6):748-54. PubMed ID: 9771838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally acquired anti-alpha Gal antibodies in a murine allograft model similar to delayed xenograft rejection.
    Salvaris E; Gock H; Han W; Murray-Segal L; Barlow H; Mottram P; Pearse M; Cowan P; Goodman D; d'Apice AJ
    Xenotransplantation; 2000 Feb; 7(1):42-7. PubMed ID: 10809056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection.
    Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS
    Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice.
    McKenzie IF; Li YQ; Patton K; Thall AD; Sandrin MS
    Transplantation; 1998 Sep; 66(6):754-63. PubMed ID: 9771839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-alphaGal natural antibodies.
    Shimizu I; Smith NR; Zhao G; Medof E; Sykes M
    Transplantation; 2006 Jan; 81(1):95-100. PubMed ID: 16421483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gal mismatch alone causes skin graft rejection in mice.
    Gock H; Murray-Segal L; Salvaris E; Cowan PJ; D'Apice AJ
    Transplantation; 2002 Sep; 74(5):637-45. PubMed ID: 12352879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-alpha1,3-galactose-mediated hyperacute rejection of vascularized transplants in a small animal model.
    Gock H; Salvaris E; Han W; Murray-Segal L; Mottram P; Cowan P; Goodman DJ; d'Apice AJ
    Transplant Proc; 2000 Nov; 32(7):2075. PubMed ID: 11120073
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.
    Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS
    Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal porcine thymus engraftment, survival and CD4 reconstitution in alphaGal-KO mice is impaired in the presence of high levels of antibodies against alphaGal.
    Rodriguez-Barbosa JI; Zhao Y; Houser S; Zhao G; Sykes M
    Xenotransplantation; 2003 Jan; 10(1):24-40. PubMed ID: 12535223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts.
    McGregor CG; Ricci D; Miyagi N; Stalboerger PG; Du Z; Oehler EA; Tazelaar HD; Byrne GW
    Transplantation; 2012 Apr; 93(7):686-92. PubMed ID: 22391577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of αGal on corneal xenotransplantation in a mouse model.
    Choi HJ; Kim MK; Lee HJ; Jeong SH; Kang HJ; Park CS; Park CG; Joon Kim S; Wee WR
    Xenotransplantation; 2011; 18(3):176-82. PubMed ID: 21696447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucosyl transferase (H) transgenic heart transplants to Gal-/- mice.
    McKenzie IF; Li YQ; Patton K; Sandrin MS
    Transplantation; 2000 Oct; 70(8):1205-9. PubMed ID: 11063342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous synthetic alphaGal saccharides delay hyperacute rejection following pig-to-baboon heart transplantation.
    Romano E; Neethling FA; Nilsson K; Kosanke S; Shimizu A; Magnusson S; Svensson L; Samuelsson B; Cooper DK
    Xenotransplantation; 1999 Feb; 6(1):36-42. PubMed ID: 10355731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Gal antibodies in humans and 1, 3alpha-galactosyltransferase knock-out mice.
    Chiang TR; Fanget L; Gregory R; Tang Y; Ardiet DL; Gao L; Meschter C; Kozikowski AP; Buelow R; Vuist WM
    Transplantation; 2000 Jun; 69(12):2593-600. PubMed ID: 10910282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression.
    Murray-Segal L; Gock H; Cowan PJ; d'Apice AJ
    Xenotransplantation; 2008 Feb; 15(1):20-6. PubMed ID: 18333910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection.
    Collins BH; Cotterell AH; McCurry KR; Alvarado CG; Magee JC; Parker W; Platt JL
    J Immunol; 1995 May; 154(10):5500-10. PubMed ID: 7537308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation.
    Byrne GW; Stalboerger PG; Davila E; Heppelmann CJ; Gazi MH; McGregor HC; LaBreche PT; Davies WR; Rao VP; Oi K; Tazelaar HD; Logan JS; McGregor CG
    Xenotransplantation; 2008; 15(4):268-76. PubMed ID: 18957049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model.
    Hansen AB; Kirkeby S; Aasted B; Dahl K; Hansen AK; Dieperink H; Svendsen M; Kemp E; Buschard K; D'Apice AJ
    APMIS; 2003 Nov; 111(11):1019-26. PubMed ID: 14629268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.
    Larkin JM; Porter CD
    Cancer Immunol Immunother; 2007 Jan; 56(1):60-9. PubMed ID: 16715304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.